A powerful tool to aid in the diagnosis and monitoring of medullary thyroid carcinoma (MTC)
Thyroid carcinoma is the most common malignancy of the endocrine system. In 5 to 10% of all thyroid carcinoma patients, a medullary thyroid carcinoma (MTC) is identified.1 These carcinomas produce elevated serum concentrations of calcitonin and, therefore, can be diagnosed with an exceptional degree of accuracy and specificity using immunoassays measuring serum calcitonin.2,3
The diagnostic marker calcitonin is a sensitive and specific tumor marker aiding in the diagnosis, as well as for the life-long monitoring of MTC patients after thyroid surgery.2,3
Figure 1: Calcitonin is a highly specific marker for MTC, allowing early and specific diagnosis and reliable monitoring. Source: Performance Evaluation Study 2013, data available upon request.
* LoB = Limit of Blank; LoD = Limit of Detection; LoQ = Limit of Quantitation with a total allowable error of ≤20 %